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Malignant pleural mesothelioma is a rare cancer arising from the lining of the lung (pleura); usually as a result of previous exposure to asbestos some 20 -50 years previously. It is a uniformly fatal diagnosis (Kazan-Allen 2005, Steele and Klabatsa 2005, Szlosarek et al 2008) and its incidence is increasing worldwide. In Great Britain the total number of recorded deaths has risen from 153 in 1968 to 2,347 in 2010, and is expected to peak in this decade (Health and Safety Executive 2012).

Pleural mesothelioma is often a rapidly progressive disease with a median survival of 6 to 12 months from diagnosis (Curran et al 1998, Edwards et al 2000, O’Byrne et al 2004). Patients characteristically present with advanced disease and symptoms include breathlessness, chest wall pain, weight loss, sweating and fatigue (Pistolesi & Rusthoven 2004, Cordes & Brueggen 2003). The severity of symptoms often increases as the disease progresses and they may prove difficult to palliate (Cordes & Brueggen 2003, Chapman et al 2005, Clayson et al 2005). These factors commonly associated with mesothelioma may help to explain the high levels of psychological sequelae reported in individuals living with the disease, including anxiety, depression, anger, fear, isolation and hopelessness (Lebovits et al 1983, Clayson 2003, Cordes & Brueggen 2003, Chapman et al 2005, Hughes and Arber 2008, Arber & Spencer 2012).  

The effects of psychological distress in cancer have been well-researched. It can greatly increase the risk of developing depression and anxiety states, as well as impacting negatively on overall quality of life, marital and family relationships, compliance with treatment and even survival (Faller et al 1997, Colleoni et al 2000, Prieto et al 2002, Akechi et al 2008, Greer et al 2008). Given the palliative nature of treatment for pleural mesothelioma and the inherent need to optimise quality of life for individuals with the disease, an understanding of the factors that may impact on psychological wellbeing and the introduction of appropriate interventions to ameliorate them are crucial.

Until recently, distinct services for pleural mesothelioma have not been developed resulting in variable approaches to treatment and care (Department of Health 2007, Moore & Darlison 2011). Historically, services for mesothelioma have been provided by the existing infrastructure in place for lung cancer with assumptions being made that the care needs of individuals with either disease are the same. However, increasingly health care professionals and advocacy groups are lobbying for distinct services for individuals affected by mesothelioma in recognition that some of their care needs may be unique to their particular situation (Darlison 2008). 





The study aimed to answer the following research question: Are the psychological needs of individuals diagnosed with pleural mesothelioma the same as those diagnosed with advanced lung cancer?

The objectives were to:

	Identify papers which explore the impact of pleural mesothelioma and advanced lung cancer on psychological wellbeing
	Identify factors that are reported to cause psychological distress in individuals with mesothelioma and advanced lung cancer
	Compare and contrast the similarities and differences of these factors between the two disease populations




A systematic literature review was chosen to address the research question as it is a method that not only identifies and makes sense of the available evidence but also helps to map out areas of uncertainty and identify where further research is needed (Petticrew & Roberts 2006). In order to identify relevant papers for review, an electronic search of the databases MEDLINE, CINAHL, PsycARTICLES, Psychology and Behavioural Sciences Collection, PsychINFO (all accessed through EBSCO Host) and the Cochrane Library of Systematic Reviews was undertaken. ‘Grey literature’ was also identified and relevant reference lists searched for further papers. Studies meeting predefined inclusion and exclusion criterion (Table 1) were read and critically appraised for quality using the Critical Appraisal Skills Programme (CASP) checklist for appraising qualitative research (CASP 2013) (Box 1). 

Table 1: Inclusion and exclusion criteria for selecting papers
	Inclusion criteria	Exclusion criteria
Type of study	Qualitative studies which explore experienceMixed method studies if qualitative aspects are presented in relation to experienceEnglish language	Studies such as controlled trials and cohort studies which produce empirical explanations as opposed to experienceCase studies, review documents, commentaries and personal opinion piecesNon-English language
Clinical population and diagnosis	All adults aged 18 and over with pleural mesothelioma or advanced lung cancer (i.e. lung cancer that is inoperable or not amenable to radical treatment)	Patients with lung cancer who have had a surgical resection or completed treatment with curative/radical intentPatients with primary mesothelioma in another site e.g. peritoneum
Severity of disease	Disease where all treatments would be given with palliative intent	Early stage disease where treatments would be given with curative intent
Outcomes	Psychological issues, feelings, experience, views, perceptions, distress	Psychological outcomes assessed by quantitative tools such as quality of life scales.

Was there a clear statement of the aims of the research?Is a qualitative methodology appropriate?Was the research design appropriate to the aims of the study?Was the recruitment strategy appropriate to the aims of the study?Was the data collected in a way that addressed the research issue?Has the relationship between the researcher and participants been adequately considered?Have ethical issues been taken into consideration?Was the data analysis process sufficiently rigorous?Is there a clear statement of findings?How valuable is the research?
Box 1: CASP qualitative checklist (CASP 2013)

Each study was then awarded a grade of A, B or C where:

	‘A’ denotes the study is well conducted and reported, and there are no concerns

	‘B’ denotes some concerns relating to the way the study was conducted and/or reported but which are not severe enough to reduce the validity of the findings

	‘C’ denotes serious concerns about the study design, conduct and/or reporting which result in the findings not being deemed valid (London South Bank University 2013).

Studies graded C were excluded from the review.

Data relating to the psychological experiences of people with mesothelioma or lung cancer were extracted from the papers and synthesised narratively using a process of meta ethnography (Britten et al 2002). This process involved constructing a grid of all the key themes/concepts identified from both the mesothelioma and lung cancer studies. The grid was then used to examine each study to identify possible reciprocal or refutation translations. That is, asking of the data: 
i)	Are similar causes/experiences of psychological distress found in both populations? 
ii)	ii) Are there conflicts in the causes/experiences of psychological distress in the two disease populations? 
iii)	iii) Does evidence exist that generates a new understanding of any similarities or differences between to two populations?





During March 2013, the database searches identified 8,916 potentially eligible papers. The EBSCO Host search engine automatically removed 98 duplicates from this number. Of the remaining 8,818 papers, 8,747 were excluded by reading the title and abstract. A further 52 papers were excluded by retrieving and reading the full text to identify if they met the inclusion criteria. The nineteen remaining papers were then critically appraised using the CASP checklist and three were excluded as they were awarded a C grade. The search of grey literature revealed one further study that was deemed eligible following critical appraisal. Therefore, a total of 17 eligible papers were identified for analysis. This database search was repeated in May 2016 and no new papers meeting the inclusion criteria were identified.

Eight of the studies included individuals with mesothelioma (Chapple et al 2004, Hawley et al 2004, Clayson et al 2005, Krishnasamy et al 2007, Hughes & Arber 2008, Lee et al 2009, Ellis et al 2012, Arber & Spencer 2012) and twelve studies included individuals with lung cancer (Chapple et al 2004, Krishnasamy et al 2007, Bertero et al 2008, McCarthy & Dowling 2009, Tishelman et al 2010, Dale & Johnson 2011, Lowe & Molassiotis 2011, Dickerson 2012, Ellis et al 2012, Hoogerwerf et al 2012, Horne et al 2012, Leydon et al 2012). Three studies included both populations (Chapple et al 2004, Krishnasamy et al 2007, Ellis et al 2012.)  Most of the studies were qualitative in their methodological approach drawing on either phenomenology or grounded theory, and using structured or semi-structured patient interviews to collect data. Two mixed method studies used patient interviews alongside focus groups or quality of life/symptom questionnaires (Tishelman et al 2010, Hoogerwerf et al 2012). 





Uncertainty was identified as a factor that impacted on individuals’ psychological wellbeing in four mesothelioma studies and seven lung cancer studies. Uncertainty was related to prognosis and worries about how the disease would progress. It led to descriptions of people feeling ‘out of control’. For example:

‘I don’t know what tomorrow will bring or next month. I don’t even know if I can look to Christmas … really, I don’t know the speed of these things or …but I just don’t know’ (Arber & Spencer 2012)

‘…there are a lot of thoughts all the time….What will happen…what will happen now…further on… do I have a future.. that is something that worries me a lot .. today I am managing quite well …but what will the situation be in six months?’ (Bertero et al 2008)





This concept relates to the idea of living normally or maintaining normality. A need to live a purposeful life and fulfil social and family roles for as long as possible was identified across most of the mesothelioma and lung cancer studies. Any threat to ‘normality’ was perceived as something to avoid. For example:





The concept of hope was also identified as a theme in both the mesothelioma and lung cancer studies. However, there appeared to be a difference in the way hope was discussed in relation to the two diseases. In three of the mesothelioma studies, the authors identified that hopelessness was a theme individuals’ reports due to the incurable nature of the disease, its limited prognosis and lack of effective treatments.  For example:

‘I’ve just been on the internet site for meso and in the book that I had, they gave me on it, it said there wasn’t much point in having chemotherapy.’ (Study Arber & Spencer 2012)

In contrast in five of the lung cancer studies, hope rather than hopelessness was identified as a theme because of the availability of treatment and the aim of treatment to prolong life. In these studies the authors suggest that hope was used as a means to manage and make sense of an otherwise ‘hopeless’ situation, and enabled individuals to regain or retain a sense of control. For example:

‘I know there is no cure for it but it can be controlled …because there are things I love to do, so long as it does not disrupt life. I can handle that.’ (Dickerson 2012)





Three mesothelioma studies identified feelings of anger and betrayal because individuals blamed the development of their illness on a former employer having exposed them to asbestos. However, attributions of blame were accompanied by conflicting feelings of loyalty in some if the employer had provided them with longstanding employment. 

Three of the lung cancer studies also identify cause of disease as a source of emotional distress for individuals. However in these studies, individuals reported stigmatisation because of the disease’s association with smoking and, although regrets about smoking are evident, expressions of blame were not explicit. 

‘But it [smoking] was fashion in the sixties. It was fashion. You went along with it and once you’re on it you can’t get off it. But even now when you say “oh I had lung cancer”, they look at you and say “did you smoke?” People automatically think you’ve brought it on yourself and it’s a sort of stigma.’ (Chapple et al 2004)

Only one of the mesothelioma studies identifies stigma as a theme and source of distress. This is in relation to other people’s reactions in response to a cancer diagnosis. For example:





This concept relates to concerns and fears expressed by individuals in relation to family members and/or carers. The concept was identified across both the mesothelioma and lung cancer studies. It commonly manifested as a fear of becoming a burden, and also of causing upset and pain to others. For example:
	
‘I worry for the family, more than, their feelings, more than my own.’ (Dale & Johnson 2011)





Physical symptoms were identified as a source of psychological distress for patients in four of the mesothelioma studies and four of the lung cancer studies. Physical symptoms were reported to cause distress through a number of mechanisms including their impact on social roles and the person’s independence, their intensity and speed of onset, and their significance as a marker of progressive disease and impending death. For example:





Delays in diagnosis were also reported to be a source of distress across both the mesothelioma and lung cancer studies, impacting on individuals’ ability to come to terms with the illness experience. For example 

‘The doctor kept saying it was muscular; he [patient] must have strained himself ‘til it got too late. It [the cancer] got a lot worse that it should’ve been. It should have been much more treatable .. Annoying, yes, and frustrating and very difficult to come to terms with.’ (Ellis et al 2012)

Other factors relating to individuals’ experiences of being diagnosed were reported as distressing in the mesothelioma studies. Two studies identified the timing of information regarding potential compensation and benefit claims as a cause of distress. For example:

‘But that was the last thing on my mind. I can’t be bothered to go through claiming you know. It was such a shock ahm.’ (Arber & Spencer 2012)





This concept relates to distress caused by contact with the health care system and was identified across most studies (i.e. 15 of 17). In the mesothelioma studies, specific issues include poor communication regarding responsibility for care and treatment decisions, fragmented and uncoordinated care, and a lack of supportive care provision particularly in relation to referral for specialist palliative support. For example:

‘I saw the respiratory physician on 26th March. I was then sent to hospital B for a CAT scan. We went back to the respiratory specialist on 4th April … [the respiratory specialist] said I want to send you to Dr A [surgeon] at hospital C. We went back to see the surgeon on 5th May and that is when the surgeon told us it was inoperable … The surgeon then sent me to Dr Y, the oncologist.’ (Hawley et al 2004)





This concept relates to individuals’ experience in relation to sorting out legal and financial matters. It was evident as a source of distress in all the mesothelioma studies but only one of the lung cancer studies. The completing of forms, meeting solicitors, and finding relevant documents and evidence for compensation claims was identified as an additional burden for individuals. 

However, one of the mesothelioma studies identified that pursuing compensation may also be a source of comfort for individuals in that it provided a sense of financial security. For example:





This concept relates to individuals’ fears regarding death and the process of dying. One mesothelioma study identified that individuals were concerned about how and when they would die, and described a need to ensure their affairs were in order to ease the burden on other family members.  A further study identified individuals with mesothelioma feared “suffocating to death” or “drowning” in fluid (Chapple et al 2004) . 

Two lung cancer studies also identified that individuals were concerned about how they would die and whether they had enough time to be able to conclude their lives. Conversely, one lung cancer study identified that individuals did not actively discuss death, preferring instead to focus on the present. For example:





This study is the only systematic literature review found which specifically examines the psychological experience of mesothelioma, and the first study to compare the psychological impact of mesothelioma with that of lung cancer. The review demonstrates, through the small numbers of primary research studies found, that there is a distinct lack of research in the area of psychological morbidity in relation to individuals with either of the two diseases.  In particular, just five papers were found that focussed specifically on the psychological experience of living with mesothelioma. Two of these studies relate to Australian populations which raises questions regarding their relevance to the UK context. Similarly, given that lung cancer is the third most common cancer in the UK (Cancer Research UK (CRUK) 2016) and the most common cancer worldwide (CRUK 2014), the lack of qualitative investigation into the psychological impact of the disease was unexpected.

Participants in the studies reviewed were drawn mainly from hospital patients who were receiving or had received treatment for their disease. The sample is likely to be somewhat selected given that only just over 50% of patients with mesothelioma and around 58% of patients with lung cancer receive anti-cancer treatment (Mesothelioma UK 2011, Health Quality Improvement Partnership 2015). The data and findings therefore are likely to relate to the experiences of a sub-group of individuals who may be fitter than those who receive supportive care alone. This selection bias was poorly acknowledged across the studies and it has implications for the generalisability of the findings of the review.

The review focussed on the psychological aspects of individuals diagnosed with mesothelioma or lung cancer. However, a number of the studies identified the views and experiences of carers and family members. These were excluded from the review but with hindsight they would have added an additional and useful dimension to the study. 

A further consideration in relation to the validity of this study is that, due to time restrictions, data extraction and analysis was conducted by a single analyst. This increases the risk of interpretational bias. In addition, the research evolved from the author’s clinical experience. Therefore, bias from prior conceptions and experience may have influenced aspects of the research process, although attempts were made to reduce this through the use of structured and rigorous critical appraisal and data extraction methods. 

The aim of the review was to determine if the psychological needs of individuals with mesothelioma are the same as those of individuals with lung cancer. The findings demonstrate areas of similarities and discrepancies between the two populations. Tentative conclusions are made that suggest key areas where causes of psychological distress may differ and as such may require supportive care to be planned accordingly. Three main areas are discussed below. However, the credibility of the conclusions is compromised by the limitations discussed above, both within the studies examined and of this review. Therefore, further qualitative or empirical investigation is warranted to validate the findings. 

Firstly, the review suggests that hopelessness may be a significant cause of psychological distress for individuals with mesothelioma, and perhaps more so than for those with lung cancer. Although both diseases have similarly poor prognoses, it appears that the perception of greater treatment options for lung cancer fosters hope and a sense of control in individuals with the disease. A proposed area for future research, therefore, could be to explore how individuals diagnosed with mesothelioma might be helped to find meaning and hope in relation to their experience of the disease.

An additional burden for individuals with mesothelioma appears to be stress in relation to legal and financial matters. Although an important issue since many individuals will be entitled to compensation and benefits due to the industrial nature of the disease, the review suggests that more consideration should be given to the timing of discussions by health care professionals. This finding has practical implications for specialist nurses who are often involved in advising patients in relation to these matters.





Psychological distress adversely affects an individual’s experience of cancer and has been shown to be highly prevalent in those with mesothelioma and lung cancer (Chapman et al 2005, Clayson 2003). Historically care for individuals with mesothelioma has been provided within the existing infrastructure in place for lung cancer, with assumptions that the needs of the two populations are the same and do not warrant separate services (Moore et al 2010). 
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